+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ophthalmic Drugs Market by Product Type (Over-The-Counter Drugs, Prescription Drugs), Drug Class (Anti-Allergics, Anti-Glaucoma Agents, Anti-Inflammatories), Dosage Form, Route of Administration, Therapeutic Area, Patient Demographics, End User - Global Forecast 2025-2030- Product Image
Ophthalmic Drugs Market by Product Type (Over-The-Counter Drugs, Prescription Drugs), Drug Class (Anti-Allergics, Anti-Glaucoma Agents, Anti-Inflammatories), Dosage Form, Route of Administration, Therapeutic Area, Patient Demographics, End User - Global Forecast 2025-2030- Product Image
Sale

Ophthalmic Drugs Market by Product Type (Over-The-Counter Drugs, Prescription Drugs), Drug Class (Anti-Allergics, Anti-Glaucoma Agents, Anti-Inflammatories), Dosage Form, Route of Administration, Therapeutic Area, Patient Demographics, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968753
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The ophthalmic drugs market is rapidly transforming as new therapies, patient-focused product designs, and evolving regulatory policies reshape opportunities for stakeholders. Senior decision-makers need strategic insight to adapt, drive innovation, and set priorities amid shifting industry dynamics.

Market Snapshot: Ophthalmic Drugs Market Overview

The ophthalmic drugs market grew from USD 374.53 billion in 2024 to USD 401.72 billion in 2025. It is projected to expand at a CAGR of 7.47%, reaching USD 577.31 billion by 2030. This growth reflects increased demand for novel therapies addressing age-related conditions, improved drug delivery technologies, and greater integration of digital health solutions in eye care. Shifts in regional consumption patterns and the entry of new therapeutic classes are also influencing the competitive landscape and stakeholder decision-making.

Scope & Segmentation

This research delivers a comprehensive analysis of the ophthalmic drugs market, covering a broad spectrum of segments, geographical regions, and transformative technologies.

  • Product Types: Over-the-counter drugs, prescription drugs.
  • Drug Classes: Anti-allergics, anti-glaucoma agents, anti-inflammatories, antibiotics (aminoglycosides, fluoroquinolones, macrolides, tetracyclines), antifungal, antiviral, combination drugs.
  • Dosage Forms: Eye drops, gels, ointments, tablets & capsules.
  • Routes of Administration: Injectable, oral, topical.
  • Therapeutic Areas: Age-related macular degeneration (dry and wet AMD), cataracts, conjunctivitis, dry eye syndrome, glaucoma, ocular infections, retinal disorders.
  • Patient Demographics: Adult, geriatric, pediatric.
  • End Users: Hospitals, online pharmacies, ophthalmic clinics, retail pharmacies & drug stores.
  • Geographical Regions: Americas (with detailed U.S. state focus), Europe, Middle East & Africa (including key markets), Asia-Pacific (major mature and emerging markets).
  • Technologies: Gene therapies, biologics, sustained-release implants, digital health platforms, advanced drug delivery systems, additive manufacturing for devices.
  • Key Companies Analyzed: Alcon Vision LLC, Allergan PLC by AbbVie Inc., Bausch Health Companies Inc., Bayer AG, Johnson & Johnson Service, Inc., among others.

Key Takeaways for Senior Decision-Makers

  • Patient-centric approaches are becoming central, with product designs focusing on reduced dosing and improved comfort to enhance adherence and satisfaction.
  • Regulatory pathways are adapting, expediting approvals for therapies that address unmet clinical needs, driving investment and accelerating clinical timelines.
  • Advanced digital health tools—including data monitoring and teleophthalmology platforms—are influencing both patient management and commercialization strategies.
  • Operational agility is vital; organizations increasingly implement modular manufacturing and inventory strategies to bolster resilience against supply and policy disruptions.
  • Partnerships with technology firms and regional manufacturers are key to accessing innovation, navigating tariffs, and supporting sustainable expansion.

Tariff Impact: Navigating Cost and Supply Chain Pressures

Recent United States tariff adjustments are impacting sourcing strategies, prompting companies to localize or diversify their supplier networks. Firms are adopting end-to-end tracking and strategic stockpiling to maintain supply chain stability and buffer cost fluctuations. These shifts emphasize the importance of transparent, agile supply chains and strategic collaboration with regional partners.

Ophthalmic Drugs Market: Methodology & Data Sources

This analysis applies a rigorous mixed-methods approach combining primary interviews with industry stakeholders and secondary research from peer-reviewed and industry sources. Data were validated using triangulation across interviews, literature, regulatory documents, and patent filings. Analytical frameworks such as SWOT and scenario planning ensure depth and relevance in strategic recommendations.

Why This Report Matters to Decision-Makers

  • Enables proactive adaptation to emerging therapeutic trends, regulatory changes, and technology adoption across diverse regional environments.
  • Facilitates strategic planning for product development, portfolio diversification, and operational risk management in a changing market.
  • Delivers actionable insights to support critical decisions on investment, partnership, and supply chain strategy in the ophthalmic drugs sector.

Conclusion

The ophthalmic drugs market is defined by rapid evolution in science, policy, and patient care expectations. Firms that adapt strategies and leverage stakeholder insight will remain well-positioned for future growth and market leadership.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of sustained-release ocular implants to improve patient compliance in glaucoma management
5.2. Market expansion driven by regulatory approval of anti-VEGF biosimilars for retinal disease treatment
5.3. Growth of nanoemulsion and liposomal formulations enhancing ocular drug penetration for dry eye therapy
5.4. Emergence of CRISPR-based gene therapies poised to transform treatment of inherited retinal disorders
5.5. Integration of digital adherence monitoring with ophthalmic drug regimens to optimize outcomes in chronic conditions
5.6. Proliferation of Targeted Biologics for Ocular Inflammation
5.7. Advancement in Ocular Microneedle Delivery Systems
5.8. Rise of Personalized Medicine in Glaucoma Pharmacogenomic
5.9. Adoption of In-office Compounded Therapies for Refractory Cases
5.10. Expansion of Over-the-Counter (OTC) Therapeutics for Lifestyle-related Eye Strain
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Ophthalmic Drugs Market, by Product Type
8.1. Introduction
8.2. Over-The-Counter Drugs
8.3. Prescription Drugs
9. Ophthalmic Drugs Market, by Drug Class
9.1. Introduction
9.2. Anti-Allergics
9.3. Anti-Glaucoma Agents
9.4. Anti-Inflammatories
9.5. Antibiotics
9.5.1. Aminoglycosides
9.5.2. Fluoroquinolones
9.5.3. Macrolides
9.5.4. Tetracyclines
9.6. Antifungal
9.7. Antiviral
9.8. Combination Drugs
10. Ophthalmic Drugs Market, by Dosage Form
10.1. Introduction
10.2. Eye Drops
10.3. Gels
10.4. Ointments
10.5. Tablets & Capsules
11. Ophthalmic Drugs Market, by Route of Administration
11.1. Introduction
11.2. Injectable
11.3. Oral
11.4. Topical
12. Ophthalmic Drugs Market, by Therapeutic Area
12.1. Introduction
12.2. Age Related Macular Degeneration (AMD)
12.2.1. Dry AMD
12.2.2. Wet AMD
12.3. Cataracts
12.4. Conjunctivitis
12.5. Dry Eye Syndrome
12.6. Glaucoma
12.7. Ocular Infections
12.8. Retinal Disorders
13. Ophthalmic Drugs Market, by Patient Demographics
13.1. Introduction
13.2. Adult
13.3. Geriatric
13.4. Pediatric
14. Ophthalmic Drugs Market, by End User
14.1. Introduction
14.2. Hospitals
14.3. Online Pharmacies
14.4. Ophthalmic Clinics
14.5. Retail Pharmacies & Drug Stores
15. Americas Ophthalmic Drugs Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Ophthalmic Drugs Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Ophthalmic Drugs Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Alcon Vision LLC
18.3.2. Allergan PLC by AbbVie Inc.
18.3.3. Bausch Health Companies Inc.
18.3.4. Bayer AG
18.3.5. Johnson & Johnson Service, Inc.
18.3.6. Lupin Limited
18.3.7. Merck & Co.
18.3.8. Novartis AG
18.3.9. Pfizer Inc.
18.3.10. Regeneron Pharmaceuticals, Inc.
18.3.11. Santen Pharmaceutical Co., Ltd.
18.3.12. Genentech, Inc.
18.3.13. Nicox SA
18.3.14. Sun Pharmaceutical Industries, Inc.
18.3.15. Viatris Inc.
18.3.16. Somerset Pharma, LLC.
18.3.17. Ocular Therapeutix, Inc.
18.3.18. Kodiak Sciences Inc.
18.3.19. Senju Pharmaceutical Co.,Ltd.
18.3.20. Carl Zeiss AG
18.3.21. Takeda Pharmaceutical Company Limited
18.3.22. OCuSOFT Inc.
18.3.23. Lotus Pharmaceutical Co., Ltd.
18.3.24. EyePoint Pharmaceuticals, Inc.
18.3.25. Apotex Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. OPHTHALMIC DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. OPHTHALMIC DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. OPHTHALMIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. OPHTHALMIC DRUGS MARKET: RESEARCHAI
FIGURE 30. OPHTHALMIC DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 31. OPHTHALMIC DRUGS MARKET: RESEARCHCONTACTS
FIGURE 32. OPHTHALMIC DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OPHTHALMIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ANTI-ALLERGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ANTI-ALLERGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ANTI-GLAUCOMA AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ANTI-GLAUCOMA AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY MACROLIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ANTIFUNGAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ANTIFUNGAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ANTIVIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ANTIVIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY EYE DROPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRY AMD, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRY AMD, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY WET AMD, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY WET AMD, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2018-2024 (USD MILLION)
TABLE 68. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2025-2030 (USD MILLION)
TABLE 69. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY CATARACTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY CATARACTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY CONJUNCTIVITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY CONJUNCTIVITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRY EYE SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRY EYE SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY GLAUCOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY OCULAR INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY OCULAR INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2018-2024 (USD MILLION)
TABLE 112. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2025-2030 (USD MILLION)
TABLE 113. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 139. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 142. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 143. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 144. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 145. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 146. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 147. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 150. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 151. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2018-2024 (USD MILLION)
TABLE 152. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2025-2030 (USD MILLION)
TABLE 153. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 154. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 155. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. CANADA OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 162. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 163. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 164. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 165. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 168. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 169. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2018-2024 (USD MILLION)
TABLE 170. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2025-2030 (USD MILLION)
TABLE 171. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 172. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. MEXICO OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2018-2024 (USD MILLION)
TABLE 188. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2025-2030 (USD MILLION)
TABLE 189. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 252. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 253. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 254. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 255. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 256. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 257. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 258. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 259. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 260. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 261. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2018-2024 (USD MILLION)
TABLE 262. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2025-2030 (USD MILLION)
TABLE 263. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 264. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 265. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. GERMANY OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 268. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 269. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 270. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 271. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 272. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 273. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 274. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 275. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 278. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 279. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2018-2024 (USD MILLION)
TABLE 280. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2025-2030 (USD MILLION)
TABLE 281. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 282. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 283. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. FRANCE OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2018-2024 (USD MILLION)
TABLE 298. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2025-2030 (USD MILLION)
TABLE 299. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 306. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 307. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 308. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 309. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 310. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 311. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 312. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 313. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 314. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 315. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2018-2024 (USD MILLION)
TABLE 316. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2025-2030 (USD MILLION)
TABLE 317. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 318. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 319. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. ITALY OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 322. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 323. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 324. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 325. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 326. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 327. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 328. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 329. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 330. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 331. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 332. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 333. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2018-2024 (USD MILLION)
TABLE 334. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY AGE RELATED MACULAR DEGENERATION (AMD), 2025-2030 (USD MILLION)
TABLE 335. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 336. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 337. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. SPAIN OPHTHALMIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. UNITED ARAB EMIRATES OPHTHALMIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD M

Samples

Loading
LOADING...

Companies Mentioned

  • Alcon Vision LLC
  • Allergan PLC by AbbVie Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Johnson & Johnson Service, Inc.
  • Lupin Limited
  • Merck & Co.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Genentech, Inc.
  • Nicox SA
  • Sun Pharmaceutical Industries, Inc.
  • Viatris Inc.
  • Somerset Pharma, LLC.
  • Ocular Therapeutix, Inc.
  • Kodiak Sciences Inc.
  • Senju Pharmaceutical Co.,Ltd.
  • Carl Zeiss AG
  • Takeda Pharmaceutical Company Limited
  • OCuSOFT Inc.
  • Lotus Pharmaceutical Co., Ltd.
  • EyePoint Pharmaceuticals, Inc.
  • Apotex Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 401.72 Billion
Forecasted Market Value ( USD ) by 2030 $ 577.31 Billion
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Ophthalmic Drugs Market Size, Share & Trends Analysis Report by Drug Class (Steroidal Drugs, Anti-VEGF Agents), Disease, Dosage Form, Route of Administration, Product Type, Drug Type, and Region with Growth Forecasts, 2025-2030 - Product Image

Ophthalmic Drugs Market Size, Share & Trends Analysis Report by Drug Class (Steroidal Drugs, Anti-VEGF Agents), Disease, Dosage Form, Route of Administration, Product Type, Drug Type, and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Monoclonal Antibody Anti-VEGF Ophthalmic Drugs Market by Indication (Diabetic Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion), Product (Aflibercept, Bevacizumab, Brolucizumab), Type, End Use, Distribution Channel, Dosage Form - Global Forecast 2025-2030 - Product Image

Monoclonal Antibody Anti-VEGF Ophthalmic Drugs Market by Indication (Diabetic Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion), Product (Aflibercept, Bevacizumab, Brolucizumab), Type, End Use, Distribution Channel, Dosage Form - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Ophthalmic Drugs Market Report by Type, Drug Class, Indication, Dosage Form, Distribution Channel, and Region 2025-2033 - Product Image

Ophthalmic Drugs Market Report by Type, Drug Class, Indication, Dosage Form, Distribution Channel, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From
Ophthalmic Drugs: Market Share, and Growth Analysis by Product Type (Anti-Glaucoma Drugs, Anti-Allergy Drugs, Anti-infective Drugs, Ophthalmic Surgical Devices), Application, End User, Technology - Product Image

Ophthalmic Drugs: Market Share, and Growth Analysis by Product Type (Anti-Glaucoma Drugs, Anti-Allergy Drugs, Anti-infective Drugs, Ophthalmic Surgical Devices), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Ophthalmic Drug Delivery System Market by Drug Type, Delivery Device Type, Product Type, Formulation Type, Mode Of Delivery, Application, End User - Global Forecast 2025-2030 - Product Image

Ophthalmic Drug Delivery System Market by Drug Type, Delivery Device Type, Product Type, Formulation Type, Mode Of Delivery, Application, End User - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.